Cost-Effectiveness Analysis of Caspofungin Versus Voriconazole in the Empirical Antifungal Therapy of Febrile Neutropenia in China
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.141
https://www.valueinhealthjournal.com/article/S1098-3015(16)30721-5/fulltext
Title :
Cost-Effectiveness Analysis of Caspofungin Versus Voriconazole in the Empirical Antifungal Therapy of Febrile Neutropenia in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30721-5&doi=10.1016/j.jval.2016.08.141
First page :
A911
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2863